Overview
- FaceAge, a deep-learning AI, estimates biological age from facial photographs and correlates it with cancer survival outcomes.
- The tool was trained on nearly 59,000 healthy faces and validated on over 6,000 cancer patients, revealing that cancer patients appeared, on average, five years older biologically than their actual age.
- Higher biological ages predicted by FaceAge were strongly linked to worse survival outcomes, particularly for patients with a biological age exceeding 85.
- FaceAge outperformed clinicians in predicting short-term survival for patients undergoing palliative radiotherapy, improving decision-making accuracy when combined with clinical data.
- Ongoing research aims to address demographic biases, expand applications to other diseases, and explore the impact of cosmetic interventions on the tool's accuracy.